| Immunogenicity, efficacy and adverse events of adalimumab in RA patients. | |
| | |
MedLine Citation:
|
PMID: 17006705 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To assess the immunogenicity of adalimumab, a human anti-TNF-alpha mAb, we evaluated the formation of antibodies to adalimumab, efficacy and adverse events among 15 patients with highly active rheumatoid arthritis. Four patients were treated with adalimumab as monotherapy, and 11 patients with concomitant DMARDs. Disease activity was measured by DAS28. The antibodies were detected by ELISA. Thirteen (87%) patients withdrew from therapy within 45 weeks and overall 13 (87%) patients showed antibodies to adalimumab including 11 patients who withdrew from therapy. In four patients without concomitant DMARDs and in nine patients with concomitant DMARDs, we detected anti-adalimumab antibodies. Overall, five of seven patients with adverse drug reactions and all nine patients with lack of efficacy were associated with the formation of antibodies. Two antibody-positive patients developed an exantheme. The results indicate that adalimumab is, in spite of its fully human sequences, immunogenic and induces antibodies in a high rate of adalimumab-treated patients. |
| | |
Authors:
|
Niko K Bender; Christoph E Heilig; Benjamin Dröll; Jessica Wohlgemuth; Franz-Paul Armbruster; Bernhard Heilig |
Related Documents
:
|
7006525 - Seronegative chronic polyarthritis: clinical and serological correlates. 20105325 - A patient with pfeifer-weber-christian disease--successful therapy with cyclosporin a: ... 19520595 - A comparison of patient questionnaires and composite indexes in routine care of rheumat... 9355205 - Seronegative spondyloarthropathy in familial mediterranean fever. 17226115 - Improved prediction of relapse of graves' thyrotoxicosis by combined determination of t... 19434465 - Clinical predictors of obstructive sleep apnea in asian bariatric patients. |
Publication Detail:
|
Type: Clinical Trial; Journal Article Date: 2006-09-28 |
Journal Detail:
|
Title: Rheumatology international Volume: 27 ISSN: 0172-8172 ISO Abbreviation: Rheumatol. Int. Publication Date: 2007 Jan |
Date Detail:
|
Created Date: 2007-01-09 Completed Date: 2007-10-16 Revised Date: 2013-05-27 |
Medline Journal Info:
|
Nlm Unique ID: 8206885 Medline TA: Rheumatol Int Country: Germany |
Other Details:
|
Languages: eng Pagination: 269-74 Citation Subset: IM |
Affiliation:
|
Rheumapraxis Heidelberg, Wielandstr. 20, 69120, Heidelberg, Germany. n.bender@rheumapraxis-heidelberg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Antibodies, Anti-Idiotypic / immunology* Antibodies, Monoclonal / adverse effects, immunology* Antibodies, Monoclonal, Humanized Arthritis, Rheumatoid / drug therapy* Female Humans Male Middle Aged Treatment Failure |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Anti-Idiotypic; 0/Antibodies, Monoclonal; 0/Antibodies, Monoclonal, Humanized; FYS6T7F842/adalimumab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic scleros...
Next Document: Leiomyosarcoma of the inferior vena cava